Alli Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）
Condition:   Leukemia, Lymphocytic, Acute Intervention:   Biological: CART-19 cells Sponsor:   The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2018 Category: Research Source Type: clinical trials